What caused the pre-market spike in TMD.TO stock?

The spike to C$1.125 on heavy pre-market trading likely reflects concentrated buy orders or a block trade. There is no public broad press release in the snapshot, so traders should verify filings and company updates on Titan Medical’s investor page.

How does TMD.TO stock look on valuation metrics?

Valuation is mixed. Reported EPS is -1.73 and market cap is C$128,295,000. Cash per share is near C$0.07 and current ratio is 2.78. These show liquidity but also ongoing development costs for its medical device program.

What is Meyka AI’s price forecast for TMD.TO stock?

Meyka AI's forecast model projects a **C$1.45** 12-month target versus the current **C$1.125**, an implied upside of **28.89%**. Forecasts are model projections and are not guarantees; always verify with your own research.

Should I trade TMD.TO stock after this volume surge?

High volume and wide price swings increase both opportunity and risk. Use strict risk controls, monitor order book depth, and prefer limit orders in thin markets. Confirm any company news before holding positions overnight.

CA Stocks

TMD.TO Titan Medical at C$1.12 on 117,220 pre-market shares: liquidity signals upside

ByDanny Kontos February 23, 2026February 23, 2026

TMD.TO stock opened the pre-market session with a sharp move to C$1.125 on 117,220 shares, well above its 50-day average of C$0.07. The spike lifted volume to 2.55x average and pushed the intraday range from C$0.045 to C$1.125. Traders are watching liquidity and volatility after a large percentage intraday move. We track catalysts, valuation, and short-term technicals to explain the volume-driven price action.